A literature review on kidney cancer outcomes among Indigenous populations in Canada, the U.S., Australia, and New Zealand, 1990−2023
DOI:
https://doi.org/10.5489/cuaj.9546Keywords:
INDIGENOUS, KIDNEY CANCER, RISK FACTORS, INCIDENCE, MORTALITY, SURVIVALAbstract
Introduction: Rates of kidney cancer incidence and mortality have risen globally, with Indigenous populations in countries such as Canada, the U.S., New Zealand, and Australia disproportionally impacted. This literature review was aimed to summarize current evidence on kidney cancer outcomes among Indigenous populations in these countries.
Methods: A structured literature review on kidney cancer outcomes among Indigenous populations in Canada, the U.S., New Zealand, and Australia was conducted using Ovid MEDLINE and EMBASE databases. Articles that were in the English language and published between 1990 and 2023 were screened and appraised for inclusion in the review.
Results: The search strategy initially identified 1868 records, of which 136 were reviewed in detail; 74 records were included. Most studies were based in the U.S. Overall, findings demonstrated that Indigenous populations have higher incidence and mortality rates of kidney cancer compared to non-Indigenous populations. This disparity was also accompanied by a higher prevalence of or exposure to known risk factors for kidney cancer. Additionally, Indigenous populations faced barriers to accessing treatment for kidney cancer, and when treatment is received, it is often more invasive.
Conclusions: Indigenous populations in Canada and U.S. have a disproportionally higher burden of kidney cancer. These findings highlighted the need for targeted and improved cancer surveillance and control efforts in Indigenous populations. Culturally appropriate preventive measures are needed to address risk factors, carcinogenic exposures, target Indigenous-specific determinants of health, and reduce the unique barriers to accessing healthcare services.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:
- Post the Article on any Web site
- Translate or authorize a translation of the Article
- Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
- Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.
The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.
You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.
The CUA also requires you to warrant the following:
- That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
- That all individuals who have made a substantive contribution to the article are acknowledged;
- That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
- That the Article does not libel or violate the privacy rights of any third party.



